STOP CSUA: phySical acTivity, mOod and sleeP in Chronic Spontaneous Urticaria and Angioedema
Launched by ST. JAMES'S HOSPITAL, IRELAND · Dec 13, 2021
Trial Information
Current as of June 13, 2025
Unknown status
Keywords
ClinConnect Summary
Chronic spontaneous urticaria and angioedema (CSUA) is a disease of the skin characterised by hives, swellings or both that last longer than 6 weeks (1). A quarter of patients with this disease report impaired quality of life (2). Furthermore, individuals with CSUA are more likely to have depression and anxiety (3). In addition, our previous qualitative research findings have noted issues with self-compassion among this cohort (4). Fatigue and poor sleep are common (5). We seek to examine possible links between physical activity, sleep, mood and symptoms of urticaria.
For participants who ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Clinical diagnosis of chronic spontaneous urticaria with or without angioedema
- • 2. Urticaria control test score \< 12 indicating poorly controlled urticaria at time of consent
- • 3. Preference to participate in the study
- • 4. In possession of a smartphone
- Exclusion Criteria:
- • Unable or unwilling to provide informed consent
About St. James's Hospital, Ireland
St. James's Hospital, located in Dublin, Ireland, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital leverages its expertise in various medical disciplines to conduct rigorous research studies aimed at improving patient outcomes and fostering the development of new therapeutic interventions. With a multidisciplinary team of healthcare professionals and state-of-the-art facilities, St. James's Hospital is dedicated to promoting evidence-based medicine and contributing to the global medical community through its comprehensive clinical trial programs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dublin, , Ireland
Patients applied
Trial Officials
Niall Conlon
Principal Investigator
St. James's Hospital, Ireland
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials